Stragen group Company Profile

18:52 EDT 23rd March 2018 | BioPortfolio

The Stragen group started its activity in 1990 by participating in chemical factories in Italy and Norway.
After some years the Pharma generic activity was intensively developed using our expertise in selecting “niche” products and obtaining the first marketing authorisations.

Recently we were able to create our own registration and distribution network in many European countries which gives us the opportunity to market our new products either directly or through licensees with long term supply agreements.

In the future we intend to continue registering injectable, oral or topical products in order to strengthen our presence in the generic market.


Zeemansstraat 13P.O. Box 23 169
3001 KD


Phone: 31 10 43 64 889
Fax: 31 10 43 61 068

News Articles [312 Associated News Articles listed on BioPortfolio]

First subject enrolled in Phase I clinical trial of its non-opioid analgesic STR-324

(Institut Pasteur) The Stragen group announced today the enrollment of the first subject to participate in a Phase I study of STR-324, a first in the class of non-opioid analgesic discovered by the In...

Huobi Group and SBI Group reached a strategic partnership agreement to jointly develop Global ...

Huobi Group was founded in 2013. After four years of steady operation, the Group has become a leading global digital asset financial service provider in Read more...

TMX Group Limited Declares Dividend of $0.50 per Common Share

For the results of the quarter ended December 31, 2017for TMX Group, please click on the following link: About TMX Group (TSX:X) TMX Read more...

Maricann Group Inc.: Maricann Group - Lizenz zur -2-

DJ Maricann Group Inc.: Maricann Group - Lizenz zur Produktion von Cannabis Kapseln! - Übernahmeangebote bei Konkurrenten! Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Presse.....

Maricann Group Inc.: Maricann Group expandiert in -2-

DJ Maricann Group Inc.: Maricann Group expandiert in den Spirituosenmarkt - genau wie Canopy Growth! Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein N.....

Maricann Group Inc.: Maricann Group - Effizienz -2-

DJ Maricann Group Inc.: Maricann Group - Effizienz durch Automatisierung um bis zu 75 % erhöht! Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwe....

CRP Group Is Ready to Amaze 2018 CES Attendees With Their Innovative Technology

MODENA, Italy, Dec. 28, 2017/PRNewswire/ -- CRP Group along with U.S.-based partner CRP USAand Energica - the sustainable subsidiary of CRP Group Read more...

Predictive Technology Group to Acquire FlagshipHealth Group

Predictive Technology Group, Inc., a provider of data analytics for disease identification and subsequent therapeutic intervention through unique biotechnology treatments has finalized an arrangement ...

PubMed Articles [1830 Associated PubMed Articles listed on BioPortfolio]

Transcanalicular laser-assisted dacryocystorhinostomy with diode laser.

This article compares the efficacy of transcanalicular laser assisted dacryocystorhinostomy (TL DCR) with conventional external dacryocystorhinostomy (Ex DCR). All patients were randomly divided into ...

Thirty first annual symposium on etiology, pathogenesis, and treatment of Parkinson disease and other movement disorders: Presented by the Parkinson study group, huntington study group, dystonia study group, tourette syndrome study group, cooperative ataxia group, and tremor research group.

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

Medulloblastoma, the most common malignant pediatric brain tumor, is a heterogeneous disease, with the existence of at least four molecular types: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Gro...

Application of the Pentafluorosulfanyl Group as a Bioisosteric Replacement.

The success of fluorinated molecules in drug design has led medicinal chemists to search for new fluorine-containing substituents. A major recently developed group is the pentafluorosulfanyl group. Th...

Systemic granulomatous disease in dairy cattle during a dicyandiamide feeding trial.

Mature, in-calf, non-lactating, Friesian or Friesian-cross cows were fed dicyandiamide (DCD) at daily doses of 0.15 g/kg (Group 1; n=31), 0.45 g/kg (Group 2; n=21) and 0.75 g/kg (Group 3; n=12), as pa...

Clinical Trials [3533 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

The Effect of Rhubarb on Sepsis and Post-traumatic Gastrointestinal Function Failure

Random grouping by computer, divided into two groups, a group of rhubarb treatment group, another group for the placebo group.

Companies [1599 Associated Companies listed on BioPortfolio]


The Stragen Group. Pharmaceutical specialities. Development, manufacturing and registration of special generic products.Stragen has his main competence in : injectable cephalosporins, injectable vario...

Stragen group

The Stragen group started its activity in 1990 by participating in chemical factories in Italy and Norway.After some years the Pharma generic activity was intensively developed using our expertise in ...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

ACE Group

Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...

More Information about "Stragen group" on BioPortfolio

We have published hundreds of Stragen group news stories on BioPortfolio along with dozens of Stragen group Clinical Trials and PubMed Articles about Stragen group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Stragen group Companies in our database. You can also find out about relevant Stragen group Drugs and Medications on this site too.

Quick Search


Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Corporate Database Quicklinks

Searches Linking to this Company Record